Clinical Trial Update: Observational Study of Pergolide Mesylate and Cardiac Valvulopathy

View source ↗

Summary

This document reports on a completed observational study examining the association between pergolide mesylate use and cardiac valvulopathy in patients with Park…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pergolide mesylate (Pergolide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Parkinson Disease | Status: COMPLETED